ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 92618 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 92618; 2) Community: the network communities that were significantly associated with the response to NSC 92618; 3) Molecule: the relationships between components within communities and NSC 92618; 4) MDR: the compounds that were significantly associated with the NSC 92618.

NSC Compound Enrichment Correlation
NSC 728220 1-(3-Bromo-phenyl)-3-(pyridin-2-ylsulfanyl)-propenone 0.0385067071027343 0.46638856
NSC 734562 6-(3-Aminopropyl)-9-bromo-5,6-dihydro-3-nitro-5,11-dioxo-11H -indeno[1,2-c]isoquinoline Hydrochloride 0.0385067071027343 0.22594545
NSC 735318 Null 0.0385067071027343 0.35364073
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.0385067071027343 0.23137944
NSC 79563 1,3-bis(4-chlorobenzyl)-2-(phenanthren-9-yl)hexahydropyrimidine 0.0385067071027343 0.34943706
NSC 143019 METHANEDIAMINE, N,N'-BIS(1,3,4-THIADIAZOL-2-YL)- 0.0385203205529756 -0.15603166
NSC 148077 Null 0.0385203205529756 0.42832945
NSC 23936 Null 0.0385203205529756 0.2301286
NSC 373355 Saframycin R 0.0385203205529756 0.4247479
NSC 381811 Poly(oxy-1,2-ethanediyl), .alpha.-methyl-.omega.-[[3- (5-fluoro-1,2,3,4-tetrahydro-2,4-dioxo-1-pyrimidinyl)- 1-oxopropyl]oxy]- 0.0385203205529756 -0.099175394
Total:118  Current:94    [First] [Prev] [Next] [Last]